| Product Code: ETC11380386 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of anti-rheumatics to Finland in 2024 continued to see a diverse range of sources, with top exporters including Germany, Netherlands, Denmark, Sweden, and the USA. The market concentration, as measured by the HHI, remained low in 2024, indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was steady at 2.88%, with a slight growth rate of 0.14% from 2023 to 2024. This data suggests a stable and diverse market for anti-rheumatics in Finland, with continued opportunities for growth and competition among exporters.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Finland Anti Rheumatics Market Overview |
3.1 Finland Country Macro Economic Indicators |
3.2 Finland Anti Rheumatics Market Revenues & Volume, 2021 & 2031F |
3.3 Finland Anti Rheumatics Market - Industry Life Cycle |
3.4 Finland Anti Rheumatics Market - Porter's Five Forces |
3.5 Finland Anti Rheumatics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Finland Anti Rheumatics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Finland Anti Rheumatics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Finland Anti Rheumatics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Finland Anti Rheumatics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rheumatic diseases in Finland |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of rheumatic conditions |
4.2.3 Technological advancements in the development of new anti-rheumatic drugs |
4.3 Market Restraints |
4.3.1 High cost associated with anti-rheumatic medications |
4.3.2 Stringent regulatory requirements for approval of new drugs in Finland |
5 Finland Anti Rheumatics Market Trends |
6 Finland Anti Rheumatics Market, By Types |
6.1 Finland Anti Rheumatics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Finland Anti Rheumatics Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Finland Anti Rheumatics Market Revenues & Volume, By NSAIDs, 2021 - 2031F |
6.1.4 Finland Anti Rheumatics Market Revenues & Volume, By DMARDs, 2021 - 2031F |
6.1.5 Finland Anti Rheumatics Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.2 Finland Anti Rheumatics Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Finland Anti Rheumatics Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Finland Anti Rheumatics Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Finland Anti Rheumatics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Finland Anti Rheumatics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Finland Anti Rheumatics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Finland Anti Rheumatics Market Revenues & Volume, By Homecare, 2021 - 2031F |
6.4 Finland Anti Rheumatics Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Finland Anti Rheumatics Market Revenues & Volume, By Retail, 2021 - 2031F |
6.4.3 Finland Anti Rheumatics Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.4.4 Finland Anti Rheumatics Market Revenues & Volume, By Online, 2021 - 2031F |
7 Finland Anti Rheumatics Market Import-Export Trade Statistics |
7.1 Finland Anti Rheumatics Market Export to Major Countries |
7.2 Finland Anti Rheumatics Market Imports from Major Countries |
8 Finland Anti Rheumatics Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed anti-rheumatic treatments |
8.2 Average time from symptom onset to treatment initiation |
8.3 Number of clinical trials for new anti-rheumatic drugs conducted in Finland |
9 Finland Anti Rheumatics Market - Opportunity Assessment |
9.1 Finland Anti Rheumatics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Finland Anti Rheumatics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Finland Anti Rheumatics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Finland Anti Rheumatics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Finland Anti Rheumatics Market - Competitive Landscape |
10.1 Finland Anti Rheumatics Market Revenue Share, By Companies, 2024 |
10.2 Finland Anti Rheumatics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |